Recent advances in hematopoietic stem cell transplantation

Area of Science:

• Hematology
• Immunology
• Oncology

Background:

• Hematopoietic cell transplantation (HCT) has evolved from a last-resort treatment to a standard lifesaving therapy for numerous life-threatening diseases.
• Early HCT application is crucial for diseases unresponsive to conventional treatments.
• Significant progress has been made in managing post-transplant complications.

Purpose of the Study:

• To highlight the evolution and current status of Hematopoietic cell transplantation (HCT).
• To underscore the impact of advancements in reducing transplant-related morbidity and mortality.
• To outline emerging research directions in HCT.

Main Methods:

• Review of incremental advances in HCT protocols.
• Analysis of strategies to control graft-versus-host disease (GVHD).
• Evaluation of methods to mitigate infections and regimen-related toxicities.

Main Results:

• HCT is now widely utilized and successful, offering patients healthy and productive lives.
• Improved management of GVHD, infections, and toxicities has significantly reduced post-transplant morbidity and mortality.
• Increased donor options have expanded HCT accessibility.

Conclusions:

• Hematopoietic cell transplantation (HCT) is a critical and increasingly successful therapeutic option.
• Ongoing research focuses on expanding donor pools, minimizing toxicity, and preventing disease relapse post-transplant.
• Further advancements promise to enhance outcomes and broaden the application of HCT.